4 Endogenous mediators and thrombophilia

Aono, 1991, The role of cGMP in the anti-aggregating properties of BY1949, a novel dibenzoxazepine derivative, European Journal of Pharmacology, 195, 225, 10.1016/0014-2999(91)90539-3 Anggard, 1990, Endothelins, Blood Vessels, 27, 269 Arbustini, 1991, Coronary atherosclerotic plaques with and without thrombus in ischaemic heart syndromes: a morphologic, immunohistochemical and biochemical study, American Journal of Cardiology, 68, 36B, 10.1016/0002-9149(91)90383-V Asano, 1990, In vivo effects of ‘recombinant humans IL-6’ in primates: stimulated production of platelets, Blood, 75, 1602, 10.1182/blood.V75.8.1602.1602 Barrett, 1989, Inhibition of platelet-derived mitogen release by nitric oxide (EDRF), Agents and Actions, 27, 488, 10.1007/BF01972860 Bennett, 1982, Identification of the fibrinogen receptor on human platelets by photoaffinity labeling, Journal of Biological Chemistry, 257, 8049, 10.1016/S0021-9258(18)34295-9 Bentfeld, 1975, Cytochromal localisation of lysosomal enzymes in rat megakaryocytes and platelets, Journal of Clinical Investigation, 56, 1635, 10.1172/JCI108246 Bentfeld-Barker, 1982, Identification of primary lysosomes in human megakaryocytes and platelets, Blood, 59, 472, 10.1182/blood.V59.3.472.472 Bessman, 1984, The relationship of megakaryocyte ploidy to platelet volume, American Journal of Haematology, 16, 161, 10.1002/ajh.2830160208 Bhardwaj, 1988, Endothelium-derived relaxing factor inhibits platelet aggregation in human whole blood in vitro and in the rat in vivo, European Journal of Pharmacology, 157, 83, 10.1016/0014-2999(88)90474-8 Boulanger, 1990, Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide, Journal of Clinical Investigation, 85, 587, 10.1172/JCI114477 Branehog, 1975, The relation of thrombokinetics to bone marrow megakaryocytes in idiopathic thrombocytopenic purpura (ITP), Blood, 45, 551, 10.1182/blood.V45.4.551.551 Bredt, 1991, Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase, Nature, 351, 714, 10.1038/351714a0 Breton-Gorius, 1972, Ultrastructural localisation of peroxidase activity in human platelets and megakaryocytes, American Journal of Pathology, 66, 277 Bult, 1991, Dipyridamole potentiates the anti-aggregating and vasodilator activity of nitric oxide, European Journal of Pharmacology, 199, 1, 10.1016/0014-2999(91)90629-5 Burstein, 1992, Thrombocytopoiesis in normal and sublethally irradiated dogs: Response to human interleukin-6, Blood, 420, 10.1182/blood.V80.2.420.420 Busse, 1990, Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells, FEBS Letters, 275, 87, 10.1016/0014-5793(90)81445-T Cadwgan, 1991, Reduced platelet nitric oxide synthesis in essential hypertension, Journal of Vascular Biology, 3, 455A Calver, 1992, Effect of local infusion of NG-monomethyl-L-arginine in patients with hypertension. The nitric oxide dilator mechanism appears abnormal, Journal of Hypertension, 10, 1025, 10.1097/00004872-199209000-00017 Calver, 1992, Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes, Journal of Clinical Investigation, 90, 2548, 10.1172/JCI116149 Cameron, 1983, Platelet size in myocardial infarction, British Medical Journal, 287, 449, 10.1136/bmj.287.6390.449 Chester, 1990, Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries, Lancet, 336, 897, 10.1016/0140-6736(90)92269-N Cooke, 1992, Cellular mechanisms of atherogenesis and the effects of nitric oxide, Current Opinions in Cardiology, 7, 799, 10.1097/00001573-199210000-00013 Cooke, 1991, Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator, Journal of Clinical Investigation, 88, 1663, 10.1172/JCI115481 Corrigan, 1968, Changes in the blood coagulation system associated with septicemia, New England Journal of Medicine, 279, 851, 10.1056/NEJM196810172791603 Cramer, 1989, Uncoordinated expression of fibrinogen compared with thrombospondin and von Willebrand factor in maturing human megakaryocytes, Blood, 73, 1123, 10.1182/blood.V73.5.1123.1123 Creager, 1992, L-arginine improves endothelium-dependent vasodilation in hypercholesterolaemic humans, Journal of Clinical Investigation, 90, 1248, 10.1172/JCI115987 De Belder, 1993, Nitric oxide synthase activities in human myocardium, Lancet, 341, 84, 10.1016/0140-6736(93)92559-C De Graaf, 1992, Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions, Circulation, 85, 2284, 10.1161/01.CIR.85.6.2284 De Nucci, 1988, Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor, 85, 9797 Denis, 1991, Journal of Leukocyte Biology, 48, 380, 10.1002/jlb.49.4.380 Drexler, 1991, Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine, Lancet, 338, 1546, 10.1016/0140-6736(91)92372-9 Dubin, 1981, Endothelin, a potent vasoconstrictor, is a vascular smooth muscle mitogen, Journal of Vascular Medicine and Biology, 1, 13 Egashira, 1993, Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions, Journal of Clinical Investigation, 91, 29, 10.1172/JCI116183 Erne, 1988, Mean platelet volume and size distribution and their sensitivity to agonists in patients with coronary artery disease and congestive heart failure, Thrombosis and Haemostasis, 59, 259, 10.1055/s-0038-1642766 Feelisch, 1987, Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase, European Journal of Pharmacology, 139, 19, 10.1016/0014-2999(87)90493-6 Furchgott, 1980, The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature, 288, 373, 10.1038/288373a0 Geiger, 1992, Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets, 89, 1031 Gerrard, 1982, Prostaglandins and thromboxanes: ‘middlemen’ modulating platelet function in hemostasis and thrombosis, Vol. 4, 87 Goldberg, 1975, Biological regulation through opposing influences of cyclic GMP and cyclic AMP: The yin yang hypothesis, Vol. 5, 307 Giles, 1994, Platelet glycoprotein IIb-IIIa and size are increased in myocardial infarction, European Journal of Clinical Investigation, 1194, 69, 10.1111/j.1365-2362.1994.tb02062.x Gordge, 1992, Platelets from patients on haemodialysis show impaired responses to nitric oxide, Clinical Sciences, 83, 313, 10.1042/cs0830313 Gorman, 1977, Modulation of human platelet adenylate cyclase by prostacyclin (PGX), Prostaglandins, 13, 377, 10.1016/0090-6980(77)90018-1 Groves, 1992, Exogenous nitric oxide inhibits in vivo platelet adhesion following balloon angioplasty, Cardiovascular Research, 1992, 615, 10.1093/cvr/26.6.615 Hamberg, 1975, Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides, 72, 2994 Harris, 1984, The effects of low dose vincristine on megakaryocyte colony-forming cells and megakaryocyte ploidy, British Journal of Haematology, 57, 37, 10.1111/j.1365-2141.1984.tb02863.x Harrison, 1993, Platelet α granules, Blood Reviews, 7, 52, 10.1016/0268-960X(93)90024-X Hendagma, 1989, Incorporation of a circulating protein into alpha-granules of megakaryocytes, Blood, 15, 59 Henriksson, 1986, In vivo production of prostacyclin and thromboxane in patients with acute myocardial infarction, British Heart Journal, 55, 543, 10.1136/hrt.55.6.543 Hibbs, 1990, Synthesis of nitric oxide from a terminal guanidino atom of l-arginine: a molecular mechanism regulating cellular proliferation that targets intracellular iron, 189 Hirata, 1989, Endothelin is a potent mitogen for rat vascular smooth muscle cells, Atherosclerosis, 78, 225, 10.1016/0021-9150(89)90227-X Hoffman, 1989, Regulation of megakaryocytopoiesis, Blood, 74, 1196, 10.1182/blood.V74.4.1196.bloodjournal7441196 Hogan, 1988, In vivo EDRF activity influences platelet function, British Journal of Pharmacology, 94, 1020, 10.1111/j.1476-5381.1988.tb11616.x Hogman, 1993, Bleeding time prolongation and NO inhalation, Lancet, 341, 1664, 10.1016/0140-6736(93)90802-N Holmsen, 1982, Differential requirements for platelet responses: A simultaneous study of dense, alpha-granule and acid hydrolase secretion, Biochemical Journal, 208, 9, 10.1042/bj2080009 Hope, 1979, Human β thromboglobulin inhibits PGI2 production and binds to a specific site in bovine aortic endothelial cells, Nature, 282, 210, 10.1038/282210a0 Houdjik, 1985, Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III, Journal of Clinical Investigation, 75, 531, 10.1172/JCI111729 Humphries, 1990, Inhibition of collagen- and ADP-induced platelet aggregation by substance P in vivo: Involvement of endothelium-derived relaxing factor, Journal of Cardiovascular Pharmacology, 16, 292, 10.1097/00005344-199008000-00016 Hung, 1992, Nitric oxide production by monocytes in alcoholic liver disease, Journal of Hepatology, 14, 146, 10.1016/0168-8278(92)90150-N Ishibashi, 1989, Interleukin-6 is a potent thrombopoietic factor in vivo in mice, Blood, 74, 1241, 10.1182/blood.V74.4.1241.1241 Johansson, 1992, Cyclic GMP increases the rate of the calcium reflux extrusion pump in intact human platelets but has no direct effect on the dense tubular calcium accumulation system, Biochimica et Biophysica Acta, 1105, 40, 10.1016/0005-2736(92)90160-N Kimura, 1988, Structure-activity relationships of endothelin: Importance of the C-terminal moiety, Biochemistry, Biophysics Research Communication, 156, 1182, 10.1016/S0006-291X(88)80757-5 Kristensen, 1991, Platelet heterogeneity and coronary artery thrombosis, Platelets, 2, 11, 10.3109/09537109109005497 Kristensen, 1990, Differences in bleeding time and aspirin sensitivity and adrenaline between acute myocardial infarction and unstable angina, Cardiovascular Research, 24, 19, 10.1093/cvr/24.1.19 Lehman, 1991, The role of endothelin as a marker of diffuse atherosclerosis in the human, New England Journal of Medicine, 325, 997 Lelchuk, 1992, Constitutive and inducible nitric oxide synthases in human megakaryoblastic cells, Journal of Pharmacology and Experimental Therapeutics, 262, 1220 Luscher, 1989, Endothelium-derived vasoactive substances: Potential role in hypertension, atherosclerosis and vascular occlusion, Journal of Cardiovascular Pharmacology, 14, S63, 10.1097/00005344-198906146-00014 Lyons, 1992, Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line, Journal of Biological Chemistry, 267, 6470, 10.1016/S0021-9258(18)42704-4 Majerus, 1986, Arachidonate metabolism in vascular disorders, Journal of Clinical Investigation, 72, 1521, 10.1172/JCI111110 Marcus, 1965 Martin, 1989, The relationship between platelet volume and megakaryocyte ploidy, Blood Cells, 15, 108 1990 Martin, 1983, Changes in volume and density of platelets in myocardial infarction, British Medical Journal, 287, 456, 10.1136/bmj.287.6390.456 Martin, 1983, Measurement of the density of human platelets and its relationship to volume, British Journal of Haematology, 54, 337, 10.1111/j.1365-2141.1983.tb02109.x Martin, 1991, Influence of platelet size on outcome after myocardial infarction, Lancet, 338, 1409, 10.1016/0140-6736(91)92719-I Matsuoka, 1989, Inhibitory effect of 8-bromo cyclic GMP on an extracellular Ca2+-dependent arachidonic acid liberation in collagen-stimulated rabbit platelets, Biochemical Pharmacology, 38, 1841, 10.1016/0006-2952(89)90420-6 McCall, 1989, Synthesis of nitric oxide from l-arginine by neutrophils. Release and interaction with superoxide ion, Biochemical Journal, 261, 293, 10.1042/bj2610293 Mellion, 1981, Evidence for the inhibitory role of guanosine 3′,5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators, Blood, 57, 946, 10.1182/blood.V57.5.946.946 Meyers, 1982, Comparative study of platelet dense granule constituents, American Journal of Physiology, 243, R454 Milner, 1985, Shortened bleeding time in myocardial infarction and its relation to platelet mass, British Medical Journal, 290, 1767, 10.1136/bmj.290.6484.1767 Moncada, 1992, The 1991 Ulf von Euler Lecture. The l-arginine: nitric oxide pathway, Acta Physiological Scandinavica, 145, 201, 10.1111/j.1748-1716.1992.tb09359.x Moncada, 1976, An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation, Nature, 263, 663, 10.1038/263663a0 Moncada, 1977, Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the antithrombotic properties of vascular endothelium, Thrombosis Research, 11, 323, 10.1016/0049-3848(77)90185-2 Moncada, 1989, Biosynthesis of nitric oxide from l-arginine. A pathway for the regulation of cell function and communication, Biochemical Pharmacology, 38, 1709, 10.1016/0006-2952(89)90403-6 Morgan, 1989, Nitroprusside differentially inhibits ADP-stimulated calcium influx and mobilization in human platelets, Biochemical Journal, 258, 447, 10.1042/bj2580447 Nakashima, 1986, Inhibitory action of cyclic GMP on secretion, polyphosphoinositide hydrolysis and calcium mobilization in thrombin-stimulated human platelets, Biochemical and Biophysical Research Communications, 135, 1099, 10.1016/0006-291X(86)91041-7 Nava, 1991, Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?, Lancet, 338, 1555, 10.1016/0140-6736(91)92375-C Nidorf, 1989, Whole blood aggregation, thromboxane release and the lyso derivative of platelet activating factor in myocardial infarction and unstable angina, Cardiovascular Research, 23, 273, 10.1093/cvr/23.4.273 Nieuwenhuis, 1985, Human blood platelets showing no response to collagen fail to express glycoprotein Ia, Nature, 318, 470, 10.1038/318470a0 O'Malley, 1994, Do large platelets cause stroke?, Age and Ageing, 23, 3, 10.1093/ageing/23.suppl_1.P3-c Palmer, 1987, Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor, Nature, 327, 524, 10.1038/327524a0 Petros, 1991, Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock, Lancet, 338, 1557, 10.1016/0140-6736(91)92376-D Pohl, 1989, EDRF increases cyclic GMP in platelets during passage through the coronary vascular bed, Circulatory Research, 65, 1798, 10.1161/01.RES.65.6.1798 Radomski, 1991, Role of nitric oxide in endothelial cell-platelet interactions, 27 Radomski, 1987, The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide, British Journal of Pharmacology, 92, 639, 10.1111/j.1476-5381.1987.tb11367.x Radomski, 1987, Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium, Lancet, 2, 1057, 10.1016/S0140-6736(87)91481-4 Radomski, 1987, The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium, Biochemistry, Biophysics Research Communication, 148, 1482, 10.1016/S0006-291X(87)80299-1 Radomski, 1988, Isolation and washing of human platelets with nitric oxide, Thrombosis Research, 50, 537, 10.1016/0049-3848(88)90202-2 Radomski, 1990, Characterization of the l-arginine/nitric oxide pathway present in human platelets regulates aggregation, 87, 5193 Radomski, 1990, Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells, 87, 10043 Radomski, 1992, S-nitroso-glutathione inhibits platelet activation in vitro and in vivo, British Journal of Pharmacology, 107, 745, 10.1111/j.1476-5381.1992.tb14517.x Rees, 1990, Dexamethasone prevents the induction of endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock, Biochemistry, Biophysics Research Communications, 173, 541, 10.1016/S0006-291X(05)80068-3 Remuzzi, 1990, Role of endothelium-derived nitric oxide in the bleeding tendency of uremia, Journal of Clinical Investigation, 86, 1768, 10.1172/JCI114904 Rittenhouse, 1985, Activation of phospholipase C in human platelets, Vol. 15, 113 Rittenhouse-Simmons, 1977, The mobilization of arachidonic acid in platelets exposed to thrombin or ionophore A23187, Journal of Clinical Investigation, 60, 495, 10.1172/JCI108801 Ross, 1976, The pathogenesis of atherosclerosis (two parts), New England Journal of Medicine, 295, 369, 10.1056/NEJM197608122950707 Ross, 1976, The pathogenesis of atherosclerosis (two parts), New England Journal of Medicine, 295, 420, 10.1056/NEJM197608192950805 Rossaint, 1993, Inhaled nitric oxide in adult respiratory distress syndrome, New England Journal of Medicine, 328, 399, 10.1056/NEJM199302113280605 Sakuma, 1990, Dipyridamole potentiates the antiaggregating effect of EDRF, Thrombosis Research Supplement, 12, 87, 10.1016/0049-3848(90)90444-H Schror, 1988, Stimulation of coronary vascular PGI2 by organic nitrates, European Heart Journal, 9, 25, 10.1093/eurheartj/9.suppl_A.25 Scott-Burden, 1991, Regulation of vascular smooth muscle cell proliferation: Role of endothelium-derived relaxing factor (nitric oxide), Journal of Vascular Biology, 3, 445 Shattil, 1987, Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry, Blood, 70, 307, 10.1182/blood.V70.1.307.307 Sherman, 1991, Cytokine- and Pneumocystis carini-induced l-arginine oxidation by murine and human pulmonary alveolar macrophages, Journal of Protozoology, 38, 2349 Sinzinger, 1992, Modification of platelet function by isosorbide dinitrate in patients with coronary artery disease, Thrombosis Research, 65, 323, 10.1016/0049-3848(92)90163-5 Stamler, 1992, Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin, 89, 7674 Stewart, 1991, Increased plasma endothelin-1 in the early hours of acute myocardial infarction, Journal of the American College of Cardiology, 18, 38, 10.1016/S0735-1097(10)80214-1 Stewart, 1992, Elevated endothelin-1 in heart failure and loss of normal response to postural change, Circulation, 85, 510, 10.1161/01.CIR.85.2.510 Tateson, 1977, Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets, Prostaglandins, 13, 389, 10.1016/0090-6980(77)90019-3 Thompson, 1983, Platelet size as a determinant of platelet function, Journal of Laboratory and Clinical Medicine, 101, 205 Trip, 1990, Platelet hyperreactivity and prognosis in survivors of myocardial infarction, New England Journal of Medicine, 322, 1549, 10.1056/NEJM199005313222201 Trowbridge, 1984, Platelet production in myocardial infarction and sudden cardiac death, Thrombosis and Haemostasis, 52, 2701 Tschoepe, 1990, Evidence for abnormal platelet glycoprotein expression in diabetes mellitus, European Journal of Clinical Investigation, 20, 166, 10.1111/j.1365-2362.1990.tb02264.x Verbeuren, 1986, Effect of hypercholesterolemia on vascular reactivity in the rabbit. I. Endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits, Circulatory Research, 58, 552, 10.1161/01.RES.58.4.552 Vesterquist, 1985, In vivo production of thromboxane in acute myocardial infarction: a preliminary study, Thrombosis Research, 37, 459, 10.1016/0049-3848(85)90074-X Vicic, 1983, Evidence that platelet alpha-granules are a major determinant of platelet density: studies in storage pool deficiency, Thrombosis and Haemostasis, 50, 878, 10.1055/s-0038-1665333 Walter, 1989, Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system, Reviews of Physiology, Biochemistry and Pharmacology, 113, 41, 10.1007/BFb0032675 Wautier, 1989, Modulation of platelet function by SIN-1A, Journal of Cardiovascular Pharmacology, 14, S111, 10.1097/00005344-198914110-00021 Williams, 1985, Murine megakaryocyte colony stimulating factor: Its relationship to interleukin-3, Leukemia Research, 9, 1487, 10.1016/0145-2126(85)90041-4 Wright, 1992, Protective and pathological roles of nitric oxide in endotoxin shock, Cardiovascular Research, 26, 48, 10.1093/cvr/26.1.48 Wright, 1910, The histiogenesis of blood platelets, Journal of Morphology, 21, 263, 10.1002/jmor.1050210204 Yanagisawa, 1984, A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature, London, 332, 411, 10.1038/332411a0 Yanagisawa, 1988, Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide, 85, 6964 Yang, 1989, Different effects of endothelin on cyclic AMP- and cyclic GMP-mediated relaxation in human arteries and veins: comparison with norepinephrine, Journal of Cardiovascular Pharmacology, 13, 129, 10.1097/00005344-198900135-00032